Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Donor mucosal immunocytes perpetuate refractory GVHD after intestinal transplantation without engrafting in recipient bone marrow: Case report and review of the literature.

Stanley K, Ranganathan S, Mazariegos G, Bond G, Soltys K, Ganoza A, Jones K, Cieply K, Sindhi R.

Pediatr Transplant. 2019 Mar;23(2):e13350. doi: 10.1111/petr.13350. Epub 2019 Jan 22. Review.

PMID:
30672115
2.

Comparison of urinary cytology and fluorescence in situ hybridization in the detection of urothelial neoplasia: An analysis of discordant results.

McHale T, Ohori NP, Cieply KM, Sherer C, Bastacky SI.

Diagn Cytopathol. 2019 Apr;47(4):282-288. doi: 10.1002/dc.24108. Epub 2018 Nov 12.

PMID:
30417563
3.

Cell banking for regulatory T cell-based therapy: strategies to overcome the impact of cryopreservation on the Treg viability and phenotype.

Gołąb K, Grose R, Placencia V, Wickrema A, Solomina J, Tibudan M, Konsur E, Ciepły K, Marek-Trzonkowska N, Trzonkowski P, Millis JM, Fung J, Witkowski P.

Oncotarget. 2018 Jan 3;9(11):9728-9740. doi: 10.18632/oncotarget.23887. eCollection 2018 Feb 9.

4.

Comparative evaluation of simple indices using a single fasting blood sample to estimate beta cell function after islet transplantation.

Gołębiewska JE, Solomina J, Thomas C, Kijek MR, Bachul PJ, Basto L, Gołąb K, Wang LJ, Fillman N, Tibudan M, Ciepły K, Philipson L, Dębska-Ślizień A, Millis JM, Fung J, Witkowski P.

Am J Transplant. 2018 Apr;18(4):990-997. doi: 10.1111/ajt.14620. Epub 2018 Jan 21.

5.

External Validation of the Newly Developed BETA-2 Scoring System for Pancreatic Islet Graft Function Assessment.

Gołębiewska J, Solomina J, Kijek MR, Kotukhov A, Basto L, Gołąb K, Bachul PJ, Konsur E, Ciepły K, Fillman N, Wang LJ, Thomas CC, Philipson LH, Tibudan M, Krenc A, Dębska-Ślizień A, Fung J, Witkowski P.

Transplant Proc. 2017 Dec;49(10):2340-2346. doi: 10.1016/j.transproceed.2017.10.011.

6.

Pain Control, Glucose Control, and Quality of Life in Patients With Chronic Pancreatitis After Total Pancreatectomy With Islet Autotransplantation: A Preliminary Report.

Solomina J, Gołębiewska J, Kijek MR, Kotukhov A, Bachul PJ, Basto L, Gołąb K, Konsur E, Cieply K, Fillman N, Wang LJ, Thomas CC, Philipson LH, Tibudan M, Dębska-Ślizień A, Fung J, Gelrud A, Matthews JB, Witkowski P.

Transplant Proc. 2017 Dec;49(10):2333-2339. doi: 10.1016/j.transproceed.2017.10.010.

7.

Total Pancreatectomy with Islet Autotransplantation for the Ampullary Cancer. A Case Report.

Savari O, Golab K, Solomina J, Konsur E, Cieply K, Ramachandran S, Tekin Z, Schenck L, Zhang SS, Tibudan M, Posner MC, Witkowski P.

J Gastrointest Cancer. 2019 Sep;50(3):543-547. doi: 10.1007/s12029-017-0029-4. No abstract available.

8.

Oncogenic activity of amplified miniature chromosome maintenance 8 in human malignancies.

He DM, Ren BG, Liu S, Tan LZ, Cieply K, Tseng G, Yu YP, Luo JH.

Oncogene. 2017 Jun 22;36(25):3629-3639. doi: 10.1038/onc.2017.123. Epub 2017 May 8.

9.

Correlation of Classic and Molecular Cytogenetic Alterations in Soft-Tissue Sarcomas: Analysis of 46 Tumors With Emphasis on Adipocytic Tumors and Synovial Sarcoma.

Rao UN, Cieply K, Sherer C, Surti U, Gollin SM.

Appl Immunohistochem Mol Morphol. 2017 Mar;25(3):168-177. doi: 10.1097/PAI.0000000000000294.

PMID:
26808135
10.

Proliferation centres of chronic lymphocytic leukaemia/small lymphocytic lymphoma have enhanced expression of MYC protein, which does not result from rearrangement or gain of the MYC gene.

Gibson SE, Leeman-Neill RJ, Jain S, Piao W, Cieply KM, Swerdlow SH.

Br J Haematol. 2016 Oct;175(1):173-5. doi: 10.1111/bjh.13844. Epub 2015 Nov 16. No abstract available.

PMID:
26568397
11.

Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.

Pradhan D, Roy S, Quiroga-Garza G, Cieply K, Mahaffey AL, Bastacky S, Dhir R, Parwani AV.

Diagn Pathol. 2015 Sep 29;10:179. doi: 10.1186/s13000-015-0412-z.

12.

Novel fusion transcripts associate with progressive prostate cancer.

Yu YP, Ding Y, Chen Z, Liu S, Michalopoulos A, Chen R, Gulzar ZG, Yang B, Cieply KM, Luvison A, Ren BG, Brooks JD, Jarrard D, Nelson JB, Michalopoulos GK, Tseng GC, Luo JH.

Am J Pathol. 2014 Oct;184(10):2840-9. doi: 10.1016/j.ajpath.2014.06.025.

13.

Myofibroblasts of recipient origin are not the predominant mesenchymal cell in bronchiolitis obliterans in lung allografts.

Yousem SA, Sherer C, Fuhrer K, Cieply K.

J Heart Lung Transplant. 2013 Feb;32(2):266-8. doi: 10.1016/j.healun.2012.11.009. Epub 2012 Dec 20. No abstract available.

PMID:
23261282
14.

Sex-determining region Y-box 2 amplification in preneoplastic squamous lesions of the lung.

Schneider F, Luvison A, Cieply K, Dacic S.

Hum Pathol. 2013 May;44(5):706-11. doi: 10.1016/j.humpath.2012.08.006. Epub 2012 Nov 14.

PMID:
23159246
15.

Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge.

Roy S, Smith MA, Cieply KM, Acquafondata MB, Parwani AV.

Diagn Pathol. 2012 Nov 2;7:151. doi: 10.1186/1746-1596-7-151.

16.

A validation study of quantum dot multispectral imaging to evaluate hormone receptor status in ductal carcinoma in situ of the breast.

Yu J, Monaco SE, Onisko A, Bhargava R, Dabbs DJ, Cieply KM, Fine JL.

Hum Pathol. 2013 Mar;44(3):394-401. doi: 10.1016/j.humpath.2012.06.002. Epub 2012 Oct 3.

PMID:
23039940
17.

Chronic lymphocytic leukemia/small lymphocytic lymphoma with cyclin D1 positive proliferation centers do not have CCND1 translocations or gains and lack SOX11 expression.

Gradowski JF, Sargent RL, Craig FE, Cieply K, Fuhrer K, Sherer C, Swerdlow SH.

Am J Clin Pathol. 2012 Jul;138(1):132-9. doi: 10.1309/AJCPIVKZRMPF93ET.

18.

Paradoxical relationship between the degree of EGFR amplification and outcome in glioblastomas.

Hobbs J, Nikiforova MN, Fardo DW, Bortoluzzi S, Cieply K, Hamilton RL, Horbinski C.

Am J Surg Pathol. 2012 Aug;36(8):1186-93. doi: 10.1097/PAS.0b013e3182518e12.

19.

DOG1: a novel marker of salivary acinar and intercalated duct differentiation.

Chênevert J, Duvvuri U, Chiosea S, Dacic S, Cieply K, Kim J, Shiwarski D, Seethala RR.

Mod Pathol. 2012 Jul;25(7):919-29. doi: 10.1038/modpathol.2012.57. Epub 2012 Mar 30.

20.

HER2 amplification in gastroesophageal adenocarcinoma: correlation of two antibodies using gastric cancer scoring criteria, H score, and digital image analysis with fluorescence in situ hybridization.

Radu OM, Foxwell T, Cieply K, Navina S, Dacic S, Nason KS, Davison JM.

Am J Clin Pathol. 2012 Apr;137(4):583-94. doi: 10.1309/AJCPXQVS6YGHPDCY.

21.

Tumor epidermal growth factor receptor and EGFR PY1068 are independent prognostic indicators for head and neck squamous cell carcinoma.

Wheeler S, Siwak DR, Chai R, LaValle C, Seethala RR, Wang L, Cieply K, Sherer C, Joy C, Mills GB, Argiris A, Siegfried JM, Grandis JR, Egloff AM.

Clin Cancer Res. 2012 Apr 15;18(8):2278-89. doi: 10.1158/1078-0432.CCR-11-1593. Epub 2012 Feb 20.

22.

The importance of 10q status in an outcomes-based comparison between 1p/19q fluorescence in situ hybridization and polymerase chain reaction-based microsatellite loss of heterozygosity analysis of oligodendrogliomas.

Horbinski C, Nikiforova MN, Hobbs J, Bortoluzzi S, Cieply K, Dacic S, Hamilton RL.

J Neuropathol Exp Neurol. 2012 Jan;71(1):73-82. doi: 10.1097/NEN.0b013e318240fa65.

23.

Prostatic adenocarcinoma metastatic to pleomorphic liposarcoma, a "collision phenomenon": report of a case with review of pelvic collision tumors.

Roy S, Hrebinko RL, Cieply KM, Parwani AV, Rao UN.

Patholog Res Int. 2011;2011:173541. doi: 10.4061/2011/173541. Epub 2011 Aug 22.

24.

EGFR expression stratifies oligodendroglioma behavior.

Horbinski C, Hobbs J, Cieply K, Dacic S, Hamilton RL.

Am J Pathol. 2011 Oct;179(4):1638-44. doi: 10.1016/j.ajpath.2011.06.020. Epub 2011 Aug 11.

25.

Fluorescence in situ hybridization for detection of MAML2 rearrangements in oncocytic mucoepidermoid carcinomas: utility as a diagnostic test.

García JJ, Hunt JL, Weinreb I, McHugh JB, Barnes EL, Cieply K, Dacic S, Seethala RR.

Hum Pathol. 2011 Dec;42(12):2001-9. doi: 10.1016/j.humpath.2011.02.028. Epub 2011 Jul 20.

PMID:
21777943
26.

Adenosquamous carcinoma of the lung: a microdissection study of KRAS and EGFR mutational and amplification status in a western patient population.

Tochigi N, Dacic S, Nikiforova M, Cieply KM, Yousem SA.

Am J Clin Pathol. 2011 May;135(5):783-9. doi: 10.1309/AJCP08IQZAOGYLFL.

PMID:
21502435
27.

Extraskeletal osteosarcoma of subcutaneous soft tissue with lymph node and skin metastasis: a case report with fluorescence in situ hybridization analysis.

Papachristou DJ, Goodman M, Cieply K, Rao UN.

Pathol Oncol Res. 2012 Jan;18(1):107-10. doi: 10.1007/s12253-010-9349-4. Epub 2011 Jan 13. No abstract available.

28.

Progressive genetic alterations of adenoid cystic carcinoma with high-grade transformation.

Seethala RR, Cieply K, Barnes EL, Dacic S.

Arch Pathol Lab Med. 2011 Jan;135(1):123-30. doi: 10.1043/2010-0048-OAR.1.

PMID:
21204718
29.

The prognostic value of Ki-67, p53, epidermal growth factor receptor, 1p36, 9p21, 10q23, and 17p13 in skull base chordomas.

Horbinski C, Oakley GJ, Cieply K, Mantha GS, Nikiforova MN, Dacic S, Seethala RR.

Arch Pathol Lab Med. 2010 Aug;134(8):1170-6. doi: 10.1043/2009-0380-OA.1.

30.

A reappraisal of the MECT1/MAML2 translocation in salivary mucoepidermoid carcinomas.

Seethala RR, Dacic S, Cieply K, Kelly LM, Nikiforova MN.

Am J Surg Pathol. 2010 Aug;34(8):1106-21. doi: 10.1097/PAS.0b013e3181de3021.

PMID:
20588178
31.

Renal oncocytoma: a comparative clinicopathologic study and fluorescent in-situ hybridization analysis of 73 cases with long-term follow-up.

Dvorakova M, Dhir R, Bastacky SI, Cieply KM, Acquafondata MB, Sherer CR, Mercuri TL, Parwani AV.

Diagn Pathol. 2010 May 24;5:32. doi: 10.1186/1746-1596-5-32.

32.

Fine needle aspiration biopsy diagnosis of dedifferentiated liposarcoma: Cytomorphology and MDM2 amplification by FISH.

Al-Maghraby HQ, Khalbuss WE, Rao UN, Cieply K, Dacic S, Monaco SE.

Cytojournal. 2010 Apr 6;7:5. doi: 10.4103/1742-6413.62257.

33.

EGFR fluorescence in situ hybridization-positive lung adenocarcinoma: incidence of coexisting KRAS and BRAF mutations.

Chiosea S, Shuai Y, Cieply K, Nikiforova MN, Dacic S.

Hum Pathol. 2010 Aug;41(8):1053-60. doi: 10.1016/j.humpath.2010.01.008. Epub 2010 Apr 8.

PMID:
20381121
34.

PCR detectable Y chromosome-specific DNA but no intact Y chromosome-bearing cells in polymyositis biopsies of two women with male offspring.

Fitches AC, Yousem S, Cieply K, Stebbings S, Highton J, Hung NA.

Pathology. 2010 Feb;42(2):160-4. doi: 10.3109/00313020903494953.

PMID:
20085518
35.

CDKN2A and MTAP deletions in peritoneal mesotheliomas are correlated with loss of p16 protein expression and poor survival.

Krasinskas AM, Bartlett DL, Cieply K, Dacic S.

Mod Pathol. 2010 Apr;23(4):531-8. doi: 10.1038/modpathol.2009.186. Epub 2010 Jan 15.

36.

A comparison of EGFR and KRAS status in primary lung carcinoma and matched metastases.

Monaco SE, Nikiforova MN, Cieply K, Teot LA, Khalbuss WE, Dacic S.

Hum Pathol. 2010 Jan;41(1):94-102. doi: 10.1016/j.humpath.2009.06.019. Epub 2009 Sep 8.

PMID:
19740513
37.

Malignant granular cell tumor of the ulnar nerve with novel cytogenetic and molecular genetic findings.

Papachristou DJ, Palekar A, Surti U, Cieply K, McGough RL, Rao UN.

Cancer Genet Cytogenet. 2009 May;191(1):46-50. doi: 10.1016/j.cancergencyto.2009.01.011.

PMID:
19389509
38.

High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma.

Henderson YC, Shellenberger TD, Williams MD, El-Naggar AK, Fredrick MJ, Cieply KM, Clayman GL.

Clin Cancer Res. 2009 Jan 15;15(2):485-91. doi: 10.1158/1078-0432.CCR-08-0933.

39.

Primary intracranial dural-based synovial sarcoma with an unusual SYT fluorescence in situ hybridization pattern.

Horbinski C, Cieply K, Bejjani GK, McFadden K.

J Neurosurg. 2008 Nov;109(5):897-903. doi: 10.3171/JNS/2008/109/11/0897.

PMID:
18976081
40.

Chordoid glioma: a case report and molecular characterization of five cases.

Horbinski C, Dacic S, McLendon RE, Cieply K, Datto M, Brat DJ, Chu CT.

Brain Pathol. 2009 Jul;19(3):439-48. doi: 10.1111/j.1750-3639.2008.00196.x. Epub 2008 Jul 23.

PMID:
18652591
41.

HER2 gene amplification and chromosome 17 copy number do not predict survival of patients with resected pancreatic adenocarcinoma.

Sharif S, Ramanathan RK, Potter D, Cieply K, Krasinskas AM.

Dig Dis Sci. 2008 Nov;53(11):3026-32. doi: 10.1007/s10620-008-0267-1. Epub 2008 May 8.

PMID:
18463983
42.

Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis.

Yu YP, Yu G, Tseng G, Cieply K, Nelson J, Defrances M, Zarnegar R, Michalopoulos G, Luo JH.

Cancer Res. 2007 Sep 1;67(17):8043-50.

43.

Adenovirus infection within stromal cells in a pediatric small bowel allograft.

Ozolek JA, Cieply K, Walpusk J, Ranganathan S.

Pediatr Dev Pathol. 2006 Jul-Aug;9(4):321-7.

PMID:
16944984
44.

Comparison of allelic losses in chondroblastoma and primary chondrosarcoma of bone and correlation with fluorescence in situ hybridization analysis.

Papachristou DJ, Goodman MA, Cieply K, Hunt JL, Rao UN.

Hum Pathol. 2006 Jul;37(7):890-8. Epub 2006 May 22.

PMID:
16784990
45.

Significance of EGFR protein expression and gene amplification in non-small cell lung carcinoma.

Dacic S, Flanagan M, Cieply K, Ramalingam S, Luketich J, Belani C, Yousem SA.

Am J Clin Pathol. 2006 Jun;125(6):860-5.

PMID:
16690485
46.

MCM7 amplification and overexpression are associated with prostate cancer progression.

Ren B, Yu G, Tseng GC, Cieply K, Gavel T, Nelson J, Michalopoulos G, Yu YP, Luo JH.

Oncogene. 2006 Feb 16;25(7):1090-8.

PMID:
16247466
47.

Anti-tumour response despite loss of donor chimaerism in patients treated with non-myeloablative conditioning and allogeneic stem cell transplantation.

Dey BR, McAfee S, Colby C, Cieply K, Caron M, Saidman S, Preffer F, Shaffer J, Tarbell N, Sackstein R, Sachs D, Sykes M, Spitzer TR.

Br J Haematol. 2005 Feb;128(3):351-9.

PMID:
15667537
48.

Protein expression and gene amplification of epidermal growth factor receptor in thymomas.

Ionescu DN, Sasatomi E, Cieply K, Nola M, Dacic S.

Cancer. 2005 Feb 1;103(3):630-6.

49.

p63 expression in assessment of bronchioloalveolar proliferations of the lung.

Sheikh HA, Fuhrer K, Cieply K, Yousem S.

Mod Pathol. 2004 Sep;17(9):1134-40.

50.

Expression of myopodin induces suppression of tumor growth and metastasis.

Jing L, Liu L, Yu YP, Dhir R, Acquafondada M, Landsittel D, Cieply K, Wells A, Luo JH.

Am J Pathol. 2004 May;164(5):1799-806.

Supplemental Content

Loading ...
Support Center